Reports Q3 revenue $13.4M, consensus $3.4M. The Company’s cash balance totaled $237.7 million as of September 30, 2022, compared to a cash balance of $370.5 million at December 31, 2021.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ARCT:
- Biotech Alert: Searches spiking for these stocks today
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Fly Intel: Pre-market Movers
- Arcturus Therapeutics upgraded to Equal Weight from Underweight at Barclays
- Arcturus Therapeutics price target raised to $44 from $39 at Cantor Fitzgerald
